More about

Bleeding

News
October 26, 2022
1 min read
Save

Endoscopic therapy bests conservative therapy for bleeding peptic ulcer disease with clots

Endoscopic therapy bests conservative therapy for bleeding peptic ulcer disease with clots

CHARLOTTE, N.C. — Endoscopic therapy yielded lower rates of rebleeding, mortality and surgery compared with conservative therapy in patients with bleeding peptic ulcer diseases, according to a presenter at ACG Annual Scientific Meeting.

News
October 25, 2022
1 min read
Save

Prophylactic endotracheal intubation ‘should not be performed’ for upper GI bleeding

Prophylactic endotracheal intubation ‘should not be performed’ for upper GI bleeding

CHARLOTTE, N.C. — Prophylactic endotracheal intubation prior to endoscopy was not beneficial for patients with upper gastrointestinal bleeding and was instead tied to adverse risks, researchers reported at ACG 2022 Annual Scientific Meeting.

News
October 21, 2022
8 min read
Save

Shift to ‘personalized’ DAPT after PCI must balance complex bleeding, ischemic risks

Shift to ‘personalized’ DAPT after PCI must balance complex bleeding, ischemic risks

For adults who undergo PCI with a drug-eluting stent, recommendations for dual antiplatelet therapy have evolved from a standard 1-year duration for most patients to a more nuanced approach that balances risks for ischemia and bleeding.

News
October 01, 2022
1 min read
Save

Endoscopic hemostasis system cleared by FDA for nonvariceal upper GI bleeding

Endoscopic hemostasis system cleared by FDA for nonvariceal upper GI bleeding

The FDA granted clearance to Medtronic’s endoscopic hemostasis system, Nexpowder, intended to improve visibility and management of upper gastrointestinal bleeding not linked to varices, according to a company press release.

News
September 28, 2022
2 min read
Save

Long-term P2Y12 inhibitor monotherapy after PCI reduces bleeding at 3 years vs. DAPT

Long-term P2Y12 inhibitor monotherapy after PCI reduces bleeding at 3 years vs. DAPT

Long-term P2Y12 inhibition after PCI reduced bleeding at 3 years compared with dual antiplatelet therapy, with no significant differences observed for ischemic events, according to new data from the SMART-CHOICE trial.

News
September 18, 2022
3 min read
Save

Routine ultrasound improved femoral access; did not lower bleeding, vascular complications

Routine ultrasound improved femoral access; did not lower bleeding, vascular complications

BOSTON — Ultrasound-guided femoral access improved first attempt success in coronary procedures but did not reduce the occurrence of major bleeding and vascular complications vs. fluoroscopy alone, a speaker reported.

News
September 08, 2022
2 min read
Save

Most women who take anticoagulants for blood clots experience abnormal menstrual bleeding

Most women who take anticoagulants for blood clots experience abnormal menstrual bleeding

Two-thirds of women of child-bearing age who began taking anticoagulants for acute venous thromboembolism had abnormally heavy menstrual bleeding in the months that followed therapy initiation, according to data from a prospective study.

News
September 06, 2022
3 min read
Save

Asundexian inhibits factor XIa activity with no excess bleeding risk after MI, stroke

Asundexian inhibits factor XIa activity with no excess bleeding risk after MI, stroke

Asundexian on top of dual antiplatelet therapy successfully reduced factor XIa activity after acute MI and stroke with no excess bleeding risk, two speakers reported.

News
August 29, 2022
1 min read
Save

In angiography, transradial access bests transfemoral access for 30-day mortality, bleeding

In angiography, transradial access bests transfemoral access for 30-day mortality, bleeding

In a meta-analysis of seven trials of patients who had coronary angiography with or without PCI, those who had transradial access had lower 30-day rates of mortality and major bleeding compared with those who had transfemoral access.

News
August 29, 2022
3 min read
Save

No long-term ischemic risk with 1-month DAPT after PCI in high-risk patients

No long-term ischemic risk with 1-month DAPT after PCI in high-risk patients

In adults with high bleeding risk, early deintensification of dual antiplatelet therapy after PCI was associated with less bleeding and no increased ischemic risk beyond 12 months vs. standard treatment, according to a speaker.

View more